Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
This study calculated the resource utilization and direct medical costs related to age-related macular degeneration (AMD). We conducted a multicenter observational study in 1999 in seven hospital ophthalmology departments in northern and central Italy. A total of 476 patients aged over 50 years with the diagnoses were classified into three prognostic groups: (a) drusen (23.7%), (b) geographic atrophy (16.4%), and (c) retinal changes associated with choroidal neovascularization (CNV) (59.9%). In addition to the costs reimbursed by the Italian National Health Service, we estimated also patients' out of pocket expenses. The mean cost per patient per year was 383.2 euro; patients with CNV were by far the most costly (540.1 euro, vs. 158.1 euro for drusen and 147.9 euro for geographic atrophy). Hospital costs and diagnostics were the main cost determinants. Services directly paid for by patients (private consultations and OTCs) amounted to 46.5 euro for patients with CNV, 50.3 euro for drusen, and 68.8 euro for geographic atrophy. The major finding of the study was that the presence of CNV involved higher expenditure than drusen or geographic atrophy. This suggests that the costs of AMD rise significantly with the severity of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Three studies [44, 46, 47] estimated costs associated with dry AMD and more specifically geographic atrophy, the advanced form of dry AMD (Fig. 4 and Supplementary Table 4).”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [44]
In the citing paper
“Direct medical costs were reported in all studies [44, 46, 47] and were expressed as mean annual costs per patient in two [44, 46], ranging from $496 to $2,633.”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [44]
In the citing paper
“Given the absence of treatment options for dry AMD at the time of the studies’ publication, no treatment cost related to the condition was considered in any of the three studies.”
From The economic impact of retinal diseases for which gene therapy is emerging: a systematic literature review (2025) · cites this paper as [44]
Citations
Cites
Use of Ranks in One-Criterion Variance Analysis
Kruskal, W. H., & Wallis, W. A. (1952) · Journal of the American Statistical Association · doi:10.1080/01621459.1952.10483441 · Cited by 13,912 · cited 1×
“Kruskal-Wallis test [ 22 ] was used to test differences between groups.”
Method(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
The Five-year Incidence and Progression of Age-related Maculopathy
Klein, R., Klein, B. E. K., Jensen, S. C., & Meuer, S. M. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30368-6 · Cited by 1,135
Age-Related Macular Degeneration and Blindness due to Neovascular Maculopathy
Ferris, F. L., Fine, S. L., & Hyman, L. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040031330019 · Cited by 1,093
Risk factors for age-related macular degeneration
Smith, W., Assink, J., Klein, R., Mitchell, P., Klaver, C. C. W., Klein, B. E. K., Hofman, A., Jensen, S., Wang, J. J., & de Jong, P. T. V. M. (2001) · Ophthalmology · doi:10.1016/s0161-6420(00)00580-7 · Cited by 1,071 · cited 2×
“The disease is rare before the age of 65 years, but its prevalence increases exponentially with age,being present in almost 5% of those aged 75–84 years and reaching a frequency of 13% among those aged 85 or over in population-based studies [1].”
BackgroundKAHN, H. A., LEIBOWITZ, H. M., GANLEY, J. P., KINI, M. M., COLTON, T., NICKERSON, R. S., & DAWBER, T. R. (1977) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112428 · Cited by 752
Bressler, N. M. (2001) · Cited by 599
Brody, B. L., Gamst, A. C., Williams, R. A., Smith, A. R., Lau, P. W., Dolnak, D., Rapaport, M. H., Kaplan, R. M., & Brown, S. I. (2001) · Ophthalmology · doi:10.1016/s0161-6420(01)00754-0 · Cited by 581
The Psychosocial Impact of Macular Degeneration
Williams, R. A. (1998) · Archives of Ophthalmology · doi:10.1001/archopht.116.4.514 · Cited by 423
Cited by
Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review
Schultz, N. M., Bhardwaj, S., Barclay, C., Gaspar, L., & Schwartz, J. J. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.08.011 · Cited by 185
The economics of vision impairment and its leading causes: A systematic review
Marques, A. P., Ramke, J., Cairns, J., Butt, T., Zhang, J. H., Jones, I., Jovic, M., Nandakumar, A., Faal, H., Taylor, H., et al. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101354 · Cited by 137
Patel, P. J., Ziemssen, F., Ng, E., Muthutantri, A., Silverman, D., Tschosik, E. A., & Cantrell, R. A. (2020) · Clinical Ophthalmology · doi:10.2147/opth.s226425 · Cited by 61
Eye-Related Medicare Costs for Patients with Age-Related Macular Degeneration from 1995 to 1999
Coleman, A. L., & Yu, F. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2007.04.016 · Cited by 45
The Burden of Age-Related Macular Degeneration
Schmier, J. K., Jones, M. L., & Halpern, M. T. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624040-00003 · Cited by 43
Metadata
- Authors
- Ricci, E., Garattini, L., Castelnuovo, E., Lanzetta, P., Viscarra, C., & Parazzini, F.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- University of Udine (IT)
- Corresponding author
- Garattini, Livio
- Venue
- The European Journal of Health Economics
- Published
- 2004-02-01
- Volume
- 5
- Issue
- 1
- Pages
- 22-27
- ISSN
- 1439-3972 (ISSN-L)
- 1618-7598
- 1618-7601
- OpenAlex
- W1971179007
- Cited by
- 19
- References
- 20
- Citations by year
- 2025: 2 · 2024: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 2 · 2016: 1 · 2015: 1 · 2012: 1
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The European Journal of Health Economics (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- age-related macular degeneration, direct medical costs, hospital resource utilization, choroidal neovascularization, drusen, geographic atrophy, out-of-pocket costs, health care expenditure, Italian National Health Service, ophthalmology department
- MeSH terms
- Aged, Female, Hospital Departments, Humans, Italy, Macular Degeneration, Male, Prospective Studies, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. https://app.cochat.ai/papers/10.1007/s10198-003-0198-x
- The paper
- Ricci, E., Garattini, L., Castelnuovo, E., Lanzetta, P., Viscarra, C., & Parazzini, F. (2004). Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. The European Journal of Health Economics. https://doi.org/10.1007/s10198-003-0198-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.